What are the benefits of Cefprozil Dispersible Tablets?

Cefprozil Dispersible Tablets has a good therapeutic effect on mild to moderate infections caused by sensitive bacteria, and is often used in the treatment of upper respiratory tract infections, such as tonsillitis, pharyngitis, etc. It also has a good therapeutic effect on lower respiratory tract infections, such as acute bronchitis bacterial infections caused by Streptococcus pneumoniae. It can also be used for skin and soft tissue infections.

1. Upper respiratory tract infections including suppurative streptococcal tonsillitis, pharyngitis. For the treatment and prevention of streptococcal infections (including the prevention of rheumatic fever), intramuscular injection of penicillin should be selected. Although cefprozil can generally effectively eliminate streptococcus in the nasopharynx, there is currently no available information on the prevention of secondary rheumatic fever by cefprozil. Haemophilus influenzae (including β-lactamase-producing strains), Streptococcus pneumoniae, and Moraxella catarrhalis (including β-lactamase-producing strains) otitis media.

2. Lower respiratory tract infections, including acute bronchitis secondary bacterial infections and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae, Moraxella catarrhalis (including β-lactamase-producing strains), and Haemophilus influenzae (including β-lactamase-producing strains).

3. Skin and skin soft tissue infections caused by Streptococcus pyogenes and Staphylococcus aureus (including penicillinase-producing strains). However, abscesses usually require surgical drainage for pus removal. Bacterial culture and drug sensitivity test should be performed to determine the sensitivity of the pathogen to cefprozil when appropriate.